glp 1 hub podcast The Truth About GLP-1s: What No One Tells You with Ana Reisdorf From Injections to Pills: Breaking

The pace of interchangeability approvals is accelerating as biosimilar developers invest in the required switching studies because the commercial payoff justifies the investment

Effects of glucose and meal ingestion on incretin secretion in Japanese subjects with normal glucose tolerance

C.RocheJ

Cigna subsidiary to cap employer spending on GLP-1s Executives said the move will offer plans and employers greater predictability and control. less than 3 min read Cigna will cap how much employers and health plans spend on GLP-1sdiabetes drugs that have become popular weight loss options despite their hefty price tagscompany executives announced Thursday

The FDA prescribing information specifically warns about the risk of acute kidney injury in patients who experience severe gastrointestinal adverse reactions

These medicines mimic the action of the naturally occurring GLP-1 hormone, which is released by the intestine in response to food intake